Pulmonary Arterial Hypertension Soluble Guanylate Cyclase–Stimulator Trial 1 - PATENT-1

Description:

Riociguat is a novel pulmonary vasodilator that acts via stimulation of soluble guanylate cyclase (sGC).The current trial sought to study the safety and efficacy of riociguat in patients with symptomatic pulmonary arterial hypertension (PAH).